Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4609]

Predicting chemotherapy response and tailoring treatments for pancreatic cancer patients

Predicting chemotherapy response and tailoring treatments for pancreatic cancer patients

FDA grants accelerated approval to amivantamab-vmjw for metastatic non-small cell lung cancer

FDA grants accelerated approval to amivantamab-vmjw for metastatic non-small cell lung cancer

FDA approves nivolumab for resected oesophageal or GEJ cancer

FDA approves nivolumab for resected oesophageal or GEJ cancer

ASCO 2021: Antibody drug conjugate shows promise against non-small cell lung cancer resistant to targeted therapy

ASCO 2021: Antibody drug conjugate shows promise against non-small cell lung cancer resistant to targeted therapy

ASCO 2021: Molecular profiling of tumour tissue can benefit many young patients with cancer, study suggests

ASCO 2021: Molecular profiling of tumour tissue can benefit many young patients with cancer, study suggests

ASCO 2021: Additional cycle of pembrolizumab before surgery improves response rates in locally advanced head and neck cancer

ASCO 2021: Additional cycle of pembrolizumab before surgery improves response rates in locally advanced head and...

New single-cell analysis tool links immune cells to kidney cancer recurrence

New single-cell analysis tool links immune cells to kidney cancer recurrence

Researchers use environmental data to assess prostate cancer diagnosis factors

Researchers use environmental data to assess prostate cancer diagnosis factors

Scientists make ‘long-range weather forecasts’ of bowel cancer’s drug resistance

Scientists make ‘long-range weather forecasts’ of bowel cancer’s drug resistance

Study reveals potential new target for treating acute myeloid leukaemia

Study reveals potential new target for treating acute myeloid leukaemia

More from ecancer